معرفی
Filippo Romiti is an Assistant Professor in the Department of Chemistry and Biochemistry at the University of Texas at Dallas, part of the School of Natural Sciences and Mathematics. He leads the Romiti Lab, which focuses on the total synthesis of complex bioactive natural products and the development of innovative synthetic methodologies.
- Assistant Professor, UT Dallas (2022–Present)
- Senior Research Associate, University of Strasbourg (2022)
- Postdoctoral Research Associate, Boston College (2018)
- Ph.D. in Chemistry, University of Glasgow (2015)
- M.Sc. in Pharmacy, Università degli Studi di Parma (2011)
His research lies at the intersection of organic synthesis and catalysis, with a strong emphasis on enantioselective transformations, macrocyclic alkene synthesis, and scalable strategies for complex molecules. The lab develops high-impact catalytic methods applicable to bioactive compounds, including anticancer agents and fluorinated pharmaceuticals.
The recent publications demonstrate a consistent trend in synthesizing structurally complex natural products such as eburnane and schizozygane alkaloids, PPAPs, and amphidinolides, using stereoselective and catalytic methods. Themes include macrocyclization, skeletal editing, and orthogonal functionalization, often published in leading journals like Science and JACS.
Notable scientific awards include:
- NSF CAREER Award (2025)
- NIH MIRA R35 Grant (2024)
- Welch Foundation Research Grant (2023)
- CPRIT Recruitment Award (2022)
- UT System Rising STARs Award (2022)
- ROAR Award, UT Dallas (2024)
Filo leads an active research group supported by major grants totaling over $5 million, including the CPRIT $2M award, NIH $1.95M, Welch $300k, and NSF CAREER $678k. He mentors graduate students and fosters a collaborative, inclusive lab environment. While specific student names are not listed, the group has produced multiple first-author publications in top journals.
The Romiti Lab operates in RL 2.712 and 2.740 at UT Dallas and is actively pursuing novel synthetic strategies for unexplored bisindole heterodimeric alkaloids and scalable routes to bioactive molecules, with a strong emphasis on catalysis and sustainability.
